Variants in the FTO (fat mass and obesity associated) gene are associated with increased body mass index in humans. Here, we show by bioinformatics analysis that FTO shares sequence motifs with Fe(II)-and 2-oxoglutarate-dependent oxygenases. We find that recombinant murine Fto catalyzes the Fe(II)-and 2OG-dependent demethylation of 3-methylthymine in single-stranded DNA, with concomitant production of succinate, formaldehyde, and carbon dioxide. Consistent with a potential role in nucleic acid demethylation, Fto localizes to the nucleus in transfected cells. Studies of wild-type mice indicate that Fto messenger RNA (mRNA) is most abundant in the Copyright 2007 by the American Association for the Advancement of Science; all rights reserved.
||To whom correspondence should be addressed. E-mail: chris.ponting@dpag.ox.ac.uk (C.P.P.); frances.ashcroft@dpag.ox.ac.uk (F.M.A.); so104@medschl.cam.ac.uk (S.O.); christopher.schofield@chem.ox.ac.uk (C.J.S.). * These authors contributed equally to this work. † These authors contributed equally to this work. ‡ These authors contributed equally to this work. § These authors contributed equally to this work. Recent studies have revealed a strong association between common variants in the first intron of FTO and obesity in both children and adults, with ~16% of studied populations homozygous for the risk alleles (1-4). As adults, these individuals weigh ~3 kg more than those homozygous for the low risk alleles as a result of a specific increase in fat mass (2). FTO mRNA is expressed in a wide range of human tissues (2). The Fto gene was first cloned after identification of a fused-toe mutant mouse whose phenotype results from a 1.6-Mb deletion of six genes, including Fto (5).Sequence analysis predicts that FTO protein contains a double-stranded beta-helix (DSBH) fold homologous to those of Fe(II) and 2-oxoglutarate (2OG) oxygenases [for a review of these enzymes, see (6)] (Fig. 1). The predicted DSBH fold of FTO contains four conserved residues characteristic of Fe(II) and 2OG binding sites (7,8), and its sequence is highly conserved in organisms ranging from mammals to green algae ( Fig. 1 and fig. S1). 2OG oxygenases are involved in diverse processes, including DNA repair, fatty acid metabolism, and posttranslational modifications, for example, proline hydroxylation and histone lysine demethylation [reviewed in (6, 9)]. They require nonheme iron [Fe(II)] as a cofactor, use oxygen and, almost always, 2OG as cosubstrates, and produce succinate and carbon dioxide as by-products.To determine whether FTO is a 2OG oxygenase, we expressed the murine Fto gene in Escherichia coli and purified N-terminally hexa-His tagged Fto (10). Some 2OG oxygenases catalyze 2OG turnover without a "prime" substrate provided that a reducing agent, typically ascorbate, is present (uncoupled turnover We next considered the identity of the prime FTO substrate. Among 2OG oxygenases with known substrates, the FTO sequence is most similar to that of the E. coli enzyme AlkB (11) and its eukaryotic hom...
ATP-sensitive potassium channels (K-ATP channels) couple cell metabolism to electrical activity and are important in the physiology and pathophysiology of many tissues. In pancreatic beta-cells, K-ATP channels link changes in blood glucose concentration to insulin secretion. They are also the target for clinically important drugs such as sulphonylureas, which stimulate secretion, and the K+ channel opener diazoxide, which inhibits insulin release. Metabolic regulation of K-ATP channels is mediated by changes in intracellular ATP and Mg-ADP levels, which inhibit and activate the channel, respectively. The beta-cell K-ATP channel is a complex of two proteins: an inward-rectifier K+ channel subunit, Kir6.2, and the sulphonylurea receptor, SUR1. We show here that the primary site at which ATP acts to mediate K-ATP channel inhibition is located on Kir6.2, and that SUR1 is required for sensitivity to sulphonylureas and diazoxide and for activation by Mg-ADP.
Sulfonylurea therapy is safe in the short term for patients with diabetes caused by KCNJ11 mutations and is probably more effective than insulin therapy. This pharmacogenetic response to sulfonylureas may result from the closing of mutant K(ATP) channels, thereby increasing insulin secretion in response to incretins and glucose metabolism. (ClinicalTrials.gov number, NCT00334711 [ClinicalTrials.gov].).
The KirBac1.1 channel belongs to the inward-rectifier family of potassium channels. Here we report the structure of the entire prokaryotic Kir channel assembly, in the closed state, refined to a resolution of 3.65 angstroms. We identify the main activation gate and structural elements involved in gating. On the basis of structural evidence presented here, we suggest that gating involves coupling between the intracellular and membrane domains. This further suggests that initiation of gating by membrane or intracellular signals represents different entry points to a common mechanistic pathway.
Diabetes is a major global problem. During the past decade, the genetic basis of various monogenic forms of the disease, and their underlying molecular mechanisms, have been elucidated. Many genes that increase type 2 diabetes (T2DM) risk have also been identified, but how they do so remains enigmatic. Nevertheless, defective insulin secretion emerges as the main culprit in both monogenic and polygenic diabetes, with environmental and lifestyle factors, via obesity, accounting for the current dramatic increase in T2DM. There also have been significant advances in therapy, particularly for some monogenic disorders. We review here what ails the β cell and how its function may be restored.
Insulin action in the central nervous system regulates energy homeostasis and glucose metabolism. To define the insulin-responsive neurons that mediate these effects, we generated mice with selective inactivation of the insulin receptor (IR) in either pro-opiomelanocortin (POMC)-or agouti-related peptide (AgRP)-expressing neurons of the arcuate nucleus of the hypothalamus. While neither POMC-nor AgRP-restricted IR knockout mice exhibited altered energy homeostasis, insulin failed to normally suppress hepatic glucose production during euglycemichyperinsulinemic clamps in AgRP-IR knockout (IR DAgRP ) mice. These mice also exhibited reduced insulin-stimulated hepatic interleukin-6 expression and increased hepatic expression of glucose-6-phosphatase. These results directly demonstrate that insulin action in POMC and AgRP cells is not required for steady-state regulation of food intake and body weight. However, insulin action specifically in AgRPexpressing neurons does play a critical role in controlling hepatic glucose production and may provide a target for the treatment of insulin resistance in type 2 diabetes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.